CC
ELV icon

Clearline Capital’s Elevance Health ELV Stock Holding History

Clearline Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,919
Closed -$1.38M – 129
2023
Q4 		$1.38M Sell
2,919
-7,928
-73% -$3.67M 0.08% 78
2023
Q3 		$4.72M Hold
10,847
– – 0.41% 63
2023
Q2 		$4.82M Sell
10,847
-4,486
-29% -$2.07M 0.28% 47
2023
Q1 		$7.05M Buy
+15,333
New +$7.3M 1.06% 33
2016
Q4 		– Sell
-13,248
Closed -$1.66M – 52
2016
Q3 		$1.66M Buy
+13,248
New +$1.71M 0.52% 38

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clearline Capital's ELV Position: Q1 2024 in Review

Clearline Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 2,919 shares — an estimated $1.38M sold.

Clearline Capital first reported a position in ELV in Q3 2016 and held it in 5 quarters. The position peaked at $7.05M in Q1 2023. 1,671 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Clearline Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • Clearline Capital sold 2,919 Elevance Health shares in Q1 2024, an estimated $1.38M.
  • Clearline Capital first reported a position in Elevance Health in Q3 2016 and held it in 5 quarters.
  • Clearline Capital's Elevance Health position peaked at $7.05M in Q1 2023.
  • 1,671 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Clearline Capital's 13F filing for Q1 2024, filed 15 May 2024.